Valeant Pharmaceuticals Intl
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$8.06avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Valeant Pharmaceuticals Intl in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Bruce & Co., Inc. ($1.4M).
- Company
- Valeant Pharmaceuticals Intl
- Filed as
- Bausch Health (Q4 2024)
- CUSIP
- 91911K102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 279,000 shares sold, net −279,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Bruce & Co., Inc. | 0.44% | Reduce -62.0% | 171,000 | $1.4M |
"% of holder's portfolio" is VALEANT PHARMACEUTICALS INTL's weight in each manager's 13F, not the share of Valeant Pharmaceuticals Intl the manager owns.